The 2nd edition of InovaBio Open is coming! Biolab, in search of innovative solutions to strengthen the pharmaceutical sector, is launching the second edition of the program in 2025, with the aim of finding mature and applicable solutions that can be transformed into impactful projects for the company. Check out the challenges and sign up using the button below!
THE INOVABIO OPEN 2025 CHALLENGES
We seek solutions that promote longevity and quality of life. These solutions can include innovative products, health monitoring technologies and preventive interventions. The aim is to provide a longer and healthier life, with a focus on promoting well-being.
We are looking for solutions that use big data and artificial intelligence to optimize the research and development of new drugs and improve the efficiency of the supply chain. Solutions can include analysis of large volumes of data to identify trends, predict demand and optimize logistics processes, with the aim of accelerating innovation and reducing costs.
We are looking for solutions that use artificial intelligence to enhance clinical research by speeding up participant recruitment and improving participant selection. Solutions can include AI algorithms that identify ideal candidates based on specific criteria, with the aim of making clinical trials more efficient and effective.
We are looking for solutions that integrate predictive analysis to anticipate trends and prospect new market strategies, monitoring of networks and communities with a focus on patients and consumer empowerment, including the impact of ChatGPT, and connecting data and internal platforms to monitor the market and government, generating value for the business.
We are looking for solutions that improve innovation management, adding value to the development of the pipeline of new products. Solutions can include project management tools, collaborative platforms and data analysis software, with the aim of speeding up development and guaranteeing the quality of innovations.
We are looking for solutions that help doctors with their day-to-day demands and bring new opportunities to their field. In addition, we are also looking for solutions that promote efficient integration between representatives, doctors and pharmaceutical retailers. Solutions can include tools such as digital platforms and mobile applications.
INOVABIO OPEN 2025 SCHEDULE
Applications open to startups from all over Brazil.
Selection of the solutions that present the most synergy with the challenges.
Presentation to the evaluation board.
Analysis and definition of the startups that will go on to the next phase.
Deepening the challenge and elaborating the scope.
Testing the solution and aligning the next steps.
Biolab stands out as a pioneer of pharmaceutical innovation in Brazil, with achievements that reflect our commitment to health and scientific advancement. Find out more about our initiatives:
UNIVERSITY-COMPANY PARTNERSHIP
We have one of the largest cases of success and payment of royalties in partnership with universities.
VONAU FLASH®
Developed in partnership with the University of São Paulo (USP)*, Vonau Flash® is an innovative medicine for treating motion sickness. Its formulation allows the tablet to dissolve quickly in the mouth, which provides accelerated relief.
*INSTITUTIONAL AND NON-PROMOTIONAL/ADVERTISING MATERIAL.
PHOTOPROT®
The result of a joint project with the Federal University of Rio Grande do Sul (UFRGS), Photoprot® is a photoprotector with a sun protection factor of 99 (SPF 99) that uses nanotechnology in its formula.
SCIENTIFIC RESEARCH
Biolab also plays an active role in promoting national scientific research. Since 2009, we have sponsored the José Ribeiro do Valle Young Investigator Award, presented annually at the Brazilian Congress of Pharmacology and Experimental Therapeutics.
PARTNERSHIPS WITH STARTUPS
Collaboration with startups is key to driving continuous innovation and bringing dynamic, adaptable solutions to new healthcare challenges. This partnership allows us to integrate cutting-edge technologies with revolutionary ideas.
ASSOCIATION WITH INNOVATIVE ENTITIES
ANPEI - To strengthen our dedication to innovation and collaborate with influential companies and institutions in stimulating national innovation, we do part of the National Association for Research and Development of Innovative Companies (ANPEI).
MIT-ILP - Reinforcing our commitment to excellence in innovation and with the firm purpose of bringing the best to Brazil, we are now members of the Massachusetts Institute of Technology (MIT), through the MIT Industrial Liaison Program (ILP).